These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67. Predictive value of a topical dexamethasone provocative test before intravitreal triamcinolone acetonide injection. Breusegem C; Vandewalle E; Van Calster J; Stalmans I; Zeyen T Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):573-6. PubMed ID: 18824737 [TBL] [Abstract][Full Text] [Related]
71. Corticosteroids in ophthalmology: drug delivery innovations, pharmacology, clinical applications, and future perspectives. Gaballa SA; Kompella UB; Elgarhy O; Alqahtani AM; Pierscionek B; Alany RG; Abdelkader H Drug Deliv Transl Res; 2021 Jun; 11(3):866-893. PubMed ID: 32901367 [TBL] [Abstract][Full Text] [Related]
72. Fluocinolone Implant Forceps: Instrument Modification for Enhanced Implant Insertion. Burke S; Albini TA; Silgado JD; Williams BK; Parel JM Int Ophthalmol Clin; 2016; 56(4):113-8. PubMed ID: 27575762 [No Abstract] [Full Text] [Related]
73. Side effects of corticosteroid injections: what's new? Berthelot JM; Le Goff B; Maugars Y Joint Bone Spine; 2013 Jul; 80(4):363-7. PubMed ID: 23352513 [TBL] [Abstract][Full Text] [Related]
74. Axial Length as a Risk Factor for Steroid-Induced Ocular Hypertension. Choi W; Kim JD; Bae HW; Kim CY; Seong GJ; Kim M Yonsei Med J; 2022 Sep; 63(9):850-855. PubMed ID: 36031785 [TBL] [Abstract][Full Text] [Related]
75. [Research progress of ocular sustained-release corticosteroid delivery systems]. Liu ZY; Chen YY Zhonghua Yan Ke Za Zhi; 2018 Feb; 54(2):154-160. PubMed ID: 29429302 [TBL] [Abstract][Full Text] [Related]
77. Challenges and opportunities for drug delivery to the posterior of the eye. Cabrera FJ; Wang DC; Reddy K; Acharya G; Shin CS Drug Discov Today; 2019 Aug; 24(8):1679-1684. PubMed ID: 31175955 [TBL] [Abstract][Full Text] [Related]